Vivos System for Pediatrics

About Vivos Therapeutics

Vivos Therapeutics is a publicly traded company pioneering a non-surgical, device-based treatment for obstructive sleep apnea. Its core technology consists of FDA-cleared oral appliances that aim to remodel the airway over a 9-12 month period, potentially resolving the condition rather than just managing symptoms. The company faces significant commercial and adoption challenges, as reflected in its micro-cap valuation, but is positioned in a large and growing sleep apnea market dominated by CPAP therapy. Its success hinges on broader insurance coverage, clinical validation, and market penetration against established alternatives.

Therapeutic Areas